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Abstract 
The precise localization of a membrane-bound, arginine-specific mono-ADP-ribosyltransferase (mADP-RT) was assessed in rabbit skeletal muscle 
by studying membrane fractions isolated by successive sucrose density gradient centrifugations. mADP-RT activity was IO-fold enriched in sarcolem- 
ma1 and T-tubular membranes. The catalytic activity, determined in preparations with mainly right-side-out vesicles, was found to be on the 
cytoplasmic face. As revealed by SDS-PAGE and autoradiography endogenous mADP-RT activity labeled several proteins in the range between 
15 kDa and 250 kDa. T-tubules contained the highest number of [“P]ADP-ribose-labeled proteins. 
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1. Introduction 
ADP-ribosylation by poly-ADP-ribosyltransferases 
(EC 2.4.2.30) or mono-ADP-ribosyltransferases 
(mADP-RT, EC 2.4.2.31) represents a post-translational 
modification. Since the initial report of Moss and 
Vaughan [l], several endogenous mADP-RTs have been 
identified in animal tissues, inchlding skeletal and car- 
diac muscle [2], and are classified according to various 
acceptor amino acid residues [3]. The reverse reaction of 
arginine-specific ADP-ribosylation is catalyzed by an 
ADP-ribosylarginine-hydrolase (EC 3.2.2.14) [4]. 
High mADP-RT activities have been detected in crude 
sarcoplasmic reticulum (SR) and sarcolemmal prepara- 
tions from pig and rabbit-skeletal muscles [2,5,6]. Hara 
et al. [7] reported endogenous ADP-ribosylation of SR 
Ca2’-ATPase, leading to an inhibition of its ATP-hy- 
drolyzing activity. A possible regulatory role of mADP- 
RT was also suggested by mono-ADP-ribosylation of 
several other microsomal proteins [8-lo]. In view of the 
as yet unidentified function of mADP-RT in cross- 
striated muscle, the exact location of this enzyme needs 
to be elucidated. Crude SR preparations are composed 
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mADP-RT, arginine-specific mono-ADP-ribosyltransferase; PMSF, 
phenylmethylsulfonyl fluoride. 
of vesicles from several membrane compartments with 
distinct protein profiles and functions, such as sar- 
colemma, T-tubules, terminal cisternae, and longitudinal 
SR. The present study was undertaken to assign mADP- 
RT activity to defined membrane compartments. For 
this purpose, crude SR was fractionated by sucrose den- 
sity centrifugation and mADP-RT activity determined in 
fractions identified by marker enzymes and specific 
ligands. Our data show that mADP-RT is predominantly 
present in vesicles derived from the T-tubules and sar- 
colemma and that its catalytic activity is oriented to- 
wards the cytoplasma. 
2. Materials and methods 
2.1. Materials 
Biochemicals and chemicals were from Sigma (alamethicin, ag- 
matine, cholera toxin subunit A, isoniacin, novobiocin, thymidine, all 
detergents). Boehringer Mannheim (NAD+, NADH, guanosine 5’-[y- 
thioltriphosphate) and Bio-Rad (Dowex AGl-X2 resin, mesh size lo& 
200). [“‘CjNicotinamide, [‘%lNAD’ and [“PINAD+ were from Amers- 
ham. 
2.2. Membrane fractionation 
Crude microsomes isolated from rabbit back muscles were fraction- 
ated by centrifugation on linear sucrose gradients (0.741.4 M) [11], 
yielding fractions Bl, B2, B3 (from heaviest o lightest). Fraction Bl 
was collected and applied to an ion-free linear sucrose gradient (0.74 
1.4 M), containing 0.05 mM PMSF. The second centrifugation yielded 
three fractions, named (from heaviest o lightest) Bl. 1, Bl.2 and Bl.3. 
Sarcolemmal membranes were isolated according to Ohlendieck et al. 
WI. 
2.3. Enzyme activities 
Mg*‘-ATPase (EC 3.6.1.3), Ca”-ATPase (EC 3.6.1.38), ouabain- 
sensitive (Na’,K’)-ATPase (EC 3.6.1.37) and lactate dehydrogenase 
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Table 1 
Biochemical properties of membrane fractions obtained by sucrose density gradient centrifugation 
Fractions 
Bl 
B2 
B3 
Bl.1 
Bl.2 
Bl.3 
SL 
Ca2’-ATPase MgZ’-ATPase (Na+,K+)-ATPase Ryanodine binding PN200- 110 binding Saxitoxin binding 
Qmol mg-’ . min-‘) Mm01 .mg-’ . mine’) (nmol . mg-’ min-‘) (pm01 .mg-‘) (pm01 .mg-‘) (pm01 .mg-‘) 
18.9 0.1 26 9.1 3.2 0.2 
21.3 1.0 140 5.4 3.1 0.3 
3.2 3.4 215 0.6 18.4 1.2 
14.4 0.5 14 1.0 2.6 0.5 
24.5 0.5 10 0.8 2.6 0.3 
3.0 1.9 129 0.2 22.2 0.6 
4.5 2.8 336 0.3 3.1 2.3 
The identity of Bl, B2, B3, Bl.l, Bl.2, Bl.3 is as described in section 3. SL is an abbreviation for sarcolemmal vesicles, isolated according to [12]. 
Values are representative of 1 independent experiments. 
(EC 1.1.1.21) activities were measured photometrically [131. Latent 
MC-ATPase and (Na’,K+)-ATPase activities were unmasked by 
alamethicin (1 mg/mg protein) and saponin (IO mg/mg protein). Ace- 
tylcholineste;ase (EC?% 1.1 .I) activity was measured according to [ 141. 
0.1% (v/v) Triton X-100 unmasked its latent activitv. Both. mADP-RT 
and GA+ glycohydrolase (EC 3.2.2.5) activities weie determined using 
the NAD+ glycohydrolase assay [15]. The reaction mixture contained 
140 ~1 of 50 mM potassium phosphate @H l.O), 2 mM [carbonyl- 
WINAD+ (60 cpm/nmol) and the indicated amount of membranes or 
purified proteins, with or without 20 mM agmatine as an acceptor for 
ADP-ribose. Detergents (C,,E,, 0.3 mg/ml) were added for membrane 
solubilization. After 60 min incubation at 3O”C, 100 ~1 aliquots were 
applied to Dowex AG l-X2 columns and washed with 5 ml of 20 mM 
Tris-HCl @H 1.3). The eluted [carbonyl-‘4C]nicotinamide was collected 
into vials containing 10 ml Ultima Gold XR (Canberra-Packard). The 
radioactivity was measured in a liquid scintillation counter. NAD+ 
glycohydrolase activity determined in the absence of agmatine was 
subtracted from the combined NAD’ glycohydrolase and mADP-RT 
activities measured in the presence of agmatine. The difference yielded 
the activity of the mADP-RT. The recovery rate of [carbonyl-‘4C]nicoti- 
namide was evaluated by using genuine [curbonyl-‘4C]nicotinamide and 
was taken into account for calculating specific activities. Recovery 
reached almost 98%. The validity of this assay was assured by using 
cholera toxin subunit Al as an authentic mADP-RT [15]. In some 
experiments, a membrane filter assay [16] was used for measuring 
mADP-RT activity. 
2.4. Binding studies 
Binding of [‘Hlryanodine, [31-IjPN200-l 10, and [‘Hlsaxitoxin to mem- 
brane fractions was determined according to [ 11-191. 
2.5. Light scattering 
Light scattering (excitation at 400 nm, emission at 401 nm) was 
measured in order to study the effect of detergents on membrane solu- 
bilization [20]. CHAPS, lysophosphatidylcholine (lysoPtdCho), n- 
octylglucoside, polyoxyethylene 9 lauryl ether (CL2E9) sodium de- 
oxycholate and saponin were chosen as detergents. 
2.6. ADP-ribosylation of membranes 
Endogenous mono-ADP ribosylation was conducted in a medium 
containing 50 mM Tris-HCl (DH 1.91. 10 mM M&l,. 1 mM EDTA. 
1 mM ATi), 0.5 mM GTP[S], l”o mM &ymidine, 20&G isoniacin, 0.1 i
(v/v) Triton X-100, 0.2 mM PMSF, 5 PM [adenylate-‘2P]NAD’, (0.5- 
4.5 @/tube) and 40 fig membrane protein. Novobiocin, an inhibitor 
of arginine-speci6c mADP-RT [21], was included in some experiments 
at 4 mM concentration. After 30 min at 3l”C, the reaction was stopped 
by adding ice-cold trichloroacetic acid to a final concentration of 20% 
(v/v). The precipitated protein was washed twice with diethylether, 
solubilized and processed for electrophoretic analysis [22]. Gels loaded 
with radioactive samples were analysed by autoradiography or by phos- 
phor-imaging. 
3. Results 
3.1. mADP-RT activities of membrane fractions 
Membrane fractions were characterized by SDS- 
PAGE (data not shown), marker enzyme activities, and 
binding of specific ligands (Table 1). Ca’+-ATPase was 
taken as a marker for longitudinal SR, MgZ’-ATPase 
and (Na+,K+)-ATPase for both sarcolemma and T-tu- 
bules. Ryanodine binding indicated the ryanodine recep- 
tor in the terminal cistemae as components of the triads. 
The binding of PN200- 110 to the dihydropyridine recep- 
tor was specific of T-Tubules, especially of junctional 
T-tubules. Finally, saxotoxin binding to the sodium 
channel was taken as a sarcolemmal marker. Thus, frac- 
tions Bl, B2, B3 were enriched in triads, longitudinal SR 
and free T-tubules, respectively. The fractions obtained 
after centrifugation of the heaviest fraction (Bl), con- 
sisted predominantly of terminal cistemae (Bl . l), longi- 
tudinal SR (B1.2) and junctional T-tubules (B1.3). 
As membrane fragments vesiculate in aqueous solu- 
tions, specific mADP-RT activities were determined in 
the presence of detergents (lysoPtdCho, n-octylgluco- 
side, C12E9), characterized as suitable for membrane sol- 
Table 2 
Specific activity of mADP-RT in subfractions from density gradient 
centrifugations of rabbit skeletal muscle microsomes 
Fractions mADP-RT activity 
(nmol . mg-’ . min-‘) 
Bl 2.18 f 1.3 
B2 3.36? 1.7 
B3 22.48 f 5.0 
B1.l 1.33 f 0.9 
Bl.2 2.26 ? 1.0 
B1.3 20.1 f 6.2 
SL 18.68 + 0.9 
Enzyme activity was determined in the presence of C,2& or 1ysoPtdCho 
(detergent to protein ratio of 10 to 1) using the NAD+ glycohydrolase 
assay. Fractions are named as indicated in Fig. 1. The values are means 
f S.D. from 1 independent preparations. 
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Fig. 1. Autoradiography (phosphoimaging) of SDS-PAGE performed 
on various membrane fractions after mono-ADP-ribosylation in the 
presence of [32P]NAD+. Lane 1, “C-methylated protein marker; lanes 
2 and 5, free T-tubules (fractions B3); lane 3, terminal cistemae (frac- 
tion B 1.1); lane 4, longitudinal sarcoplasmic reticulum (fraction B 1.2). 
The incubation shown in lane 5 contained 4 mM novobiocin, a specific 
inhibitor of arginine-specific mADP-RT [21]. 
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ubilization by changes in light-scattering [20]. Saponin 
had no effect on light scattering. At concentrations 
below the critical micellar concentration, all detergents 
induced identical increases in mADP-RT activity, most 
probably resulting from membrane perforation. How- 
ever, higher concentrations of Chaps and sodium de- 
oxycholate reduced mADP-RT activity. Sarcolemmal 
and T-tubular fractions contained lo-fold higher 
mADP-RT activities than the other fractions (Table 2). 
Higher mADP-RT activities in T-tubules and sar- 
colemma than in the other membrane fractions were also 
detected by autoradiography of SDS-PAGE after en- 
dogenous mono-ADP-ribosylation (Fig. 1) and by the 
membrane filter assay using histone as an acceptor (data 
not shown). 
3.2. Orientation of mADP-RT in T-tubular and 
sarcolemmal vesicles 
mADP-RT activity in membrane vesicles increased 
significantly after treatment with an appropriate deter- 
gent. Taking into account that the vesicles exhibited a 
defined sidedness, this tinding suggested a specific orien- 
tation of the catalytic site. The integrity and sidedness of 
the membranes was assessed by measuring patent and 
total activities of marker enzymes in the absence and 
presence of unmasking agents (Table 3). MgZ’-ATPase 
activity, recently shown to be oriented with its active site 
on the outside of the T-tubule [13,23], increased slightly 
in the presence of alamethicin. Small increases in the 
presence of unmasking agents were also observed for 
other ecto-enzymes, e.g. acetylcholinesterase [24] and 
NAD’ glycohydrolase [25] (Table 3). 
The percentage of leaky vesicles was estimated from 
patent and total lactate dehydrogenase and (Na+,K+)- 
ATPase activities [13,24]. Approximately 20% of the T- 
Table 3 
Integrity and sidedness of sarcolemma, free and junctional T-tubules as evaluated by measurement of marker enzyme activities with and without 
unmasking agents 
Marker enzymes Patent activity Total activity Vesicle subpopulation without unmasking 
Class % of total population 
Free and junctional T-tubules 
MgZ’-ATPase 1730 1930 L+RSO 89.6 
Acetylcholinesterase 6.6 8.0 L+RSO 82.5 
NAD’ glycohydrolase 62.9 73.7 L+RSO 85.4 
Lactate dehydrogenase 1160 5640 L 20.6 
(Na’,K’)-ATPase 46.6 262 L 17.8 
Sarcolemma 
Mg*‘-ATPase 2860 2840 L+RSO 100 
Acetylcholinesterase 7.6 7.6 L+RSO 100 
NAD* glycohydrolase 87.7 86.9 L+RSO 100 
Lactate dehydrogenase 607 2825 L 21.5 
(Na’,K’)-ATPase 94.2 384 L 24.5 
Values are representative of 7 independent experiments. Enzyme activities are given as nmol mg-’ min-‘. Abbreviations: L, leaky vesicles; RSO, 
right-side out vesicles. Alamethicin (1 mg/mg protein) unmasked Mg2’-ATPase and (Na’,K+)-ATPase, Triton X-100 (0.1%) acetylcholinesterase, 
CIZE9 (0.3 mg/ml) NAD+ glycohydrolase, and saponin (0.2 mg/ml) lactate dehydrogenase. 
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tubular vesicles were leaky (Table 3). Total enzyme activ- 
ity determined in the presence of unmasking agent was 
taken as the sum of inside out, right-side out and leaky 
vesicles. According to Table 3, 65-70% of the vesicles 
were scaled and right-side out, wherease 15-20% were 
leaky, leaving lO-15% sealed and inside-out. This pro- 
portion was the same in free and junctional T-tubules. 
Sarcolemmal membranes displayed 75-80% right-side 
out and 2O-25% leaky vesicles. These percentages could 
be reproduced by using detergents that did not impair 
the catalytic activities of the enzymes under study, e.g. 
CL2E9. Approximately 25% and 20% of the T-tubular and 
sarcolemmal mADP-RT activity were patent (Table 4). 
These values agreed with the percentage of both leaky 
and inside out vesicles, suggesting an orientation of the 
catalytic site on the cytoplasmic face of T-tubular and 
sarcolemmal membranes. 
3.3. Mono-ADP-ribosylation of proteins in various 
membrane fractions 
As compared to T-tubular membranes, proteins from 
terminal cisternae and longitudinal SR showed much 
smaller incorporation of [32P]ADP-ribose (Fig. 1) which 
agreed with the lower specific mADP-RT activities of 
these two fractions (Table 2). In terminal cisternae, weak 
bands were detected at 30 kDa, 55 kDa and 102 kDa 
(Fig. 1). Longitudinal SR displayed a similar profile, 
except for the absence of the 30 kDa band. T-tubules 
contained the 30 kDa, 55 kDa and 102 kDa bands and 
labeled proteins at 15,26, 37, 39,43, 60, 69, 160 and 250 
kDa. The 55 kDa, 60 kDa, 102 kDa and 160 kDa bands 
exhibited the highest incorporation. Radioactive labeling 
depended on arginine-specific mono-ADP-ribosylation 
because novobiocin, a specific inhibitor of the enzyme 
[21], almost completely abolished the incorporation of 
the label (Fig. 1, lane 5). 
4. Discussion 
Our studies on mADP-RT in skeletal muscle point to 
Table 4 
Patent and total mADP-RT activities in T-tubules and sarcolemma s 
determined by the NAD+ glycohydrolase assay in the absence and 
presence of 1ysoPtdCho r C&E, at a detergent o protein ratio of 10 
to 1 
Fractions 
Free T-tubules 
Junctional T-tubules 
Sarcolemma 
Activity 
(mnol . mg-’ . mm-‘) 
Patent Total 
7.5 30.6 
6.2 26.1 
3.7 19.1 
% latency 
24.5 
23.8 
19.4 
Values are representative for 7 independent experiments. 
a function of this enzyme in the sarcolemma and the 
T-tubules. An enrichment of mADP-RT by an order of 
magnitude in these membranes corresponds to similar 
increases of marker enzyme activities and ion channel 
ligands specific to sarcolemma nd T-tubules. This local- 
ization is confirmed by severalfold higher incorporation 
of ADP-ribose from [32P]NAD+ into proteins of the T- 
tubule membrane as compared to proteins of longitudi- 
nal SR and terminal cisternae. The specificity of argin- 
ine-specific mono-ADP-ribosylation is documented by 
the inhibitory effect of novobiocin, a specific inhibitor of 
mADP-RT [21]. 
The data on the sarcolemmal distribution are in ac- 
cordance with reports on mono-ADP ribosylation in car- 
diac and skeletal sarcolemma [5,26,27]. Here we provide 
evidence for an additional location of mADP-RT, i.e. in 
the T-tubules. Its specific activity in junctional T-tubules, 
derived from sarcolemma-free triads, exceeds that of the 
sarcolemma. Our T-tubule and sarcolemma prepara- 
tions consist mainly of sealed vesicles with right-side out 
orientation, which agrees with previously published data 
[13,23]. The patency of mADP-RT in T-tubule prepara- 
tions represents 25% of its total activity. This value 
corresponds to the sum of sealed inside-out and leaky 
vesicles. The possibility that the enzyme is trapped by 
vesiculation is excluded by the fact that mADP-RT is 
membrane-anchored [6,27,28]. Treatment with detergent 
unmasks approximately 75% of its total activity, suggest- 
ing that the catalytic site of the enzyme is on the cytoplas- 
mic surface of the membrane. The possibility that 
mADP-RT is directly activated by detergents can be ex- 
cluded since membrane perforation by saponin and low 
detergent concentration lead to identical activations. 
Also, the detergents used have no stimulatory effect on 
the purified enzyme (data not shown). 
Our findings are not in favour of an extracellular ori- 
entation of the sarcolemmal mADP-RT as recently sug- 
gested for a sarcolemmal mADP-RT in two mouse cell 
lines [28]. With the exception of the presumed integrin 
[28], all putative target proteins identified to date are 
intracellular proteins, e.g. G-proteins [29]. CAMP-inde- 
pendent protein kinase [26], proteins assigned to the SR 
[7,8,10] or the T-tubule [30]. Our results disclose addi- 
tional target proteins of endogenous mono-ADP- 
ribosylation. These are more numerous in the T-tubules 
than in longitudinal SR and terminal cisternae (Fig. 1). 
Finally, the cytoplasmic orientation of the membrane- 
bound mADP-RT (this study) together with an intracel- 
lular ADP-ribosylarginine hydrolase [31] point to the 
existence of a mono-ADP-ribosylation cycle [32] in skel- 
etal muscle. 
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